The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:

1		Dec. 31, 20Y3	Dec. 31, 20Y2
2	Assets
3	Cash	$626,170.00	$585,760.00
4	Accounts receivable (net)	227,840.00	208,880.00
5	Inventories	641,390.00	616,790.00
6	Investments	0.00	240,820.00
7	Land	327,380.00	0.00
8	Equipment	704,290.00	554,020.00
9	Accumulated depreciation-equipment	(167,160.00)	(148,930.00)
10	Total assets	$2,359,910.00	$2,057,340.00
11	Liabilities and Stockholders Equity
12	Accounts payable (merchandise creditors)	$424,670.00	$404,080.00
13	Accrued expenses payable (operating expenses)	43,080.00	52,050.00
14	Dividends payable	24,920.00	19,300.00
15	Common stock, $2 par	150,000.00	100,000.00
16	Paid-in capital: Excess of issue price over parcommon stock	417,500.00	280,000.00
17	Retained earnings	1,299,740.00	1,201,910.00
18	Total liabilities and stockholders equity	$2,359,910.00	$2,057,340.00

The income statement for the year ended December 31, 20Y3, is as follows:

1	Sales		$5,367,766.00
2	Cost of goods sold		3,306,180.00
3	Gross profit		$2,061,586.00
4	Operating expenses:
5	Depreciation expense	$18,230.00
6	Other operating expenses	1,755,888.00
7	Total operating expenses		1,774,118.00
8	Operating income		$287,468.00
9	Other income:
10	Gain on sale of investments		39,070.00
11	Income before income tax		$326,538.00
12	Income tax expense		133,028.00
13	Net income		$193,510.00

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

a. The investments were sold for $279,890 cash.

b. Equipment and land were acquired for cash.

c. There were no disposals of equipment during the year.

d. The common stock was issued for cash.

e. There was a $95,680 debit to Retained Earnings for cash dividends declared.

Livers Inc.

Statement of Cash Flows

1	Cash flows from operating activities:
2
3
4
5
6
7
8	Cash flows from investing activities:
9
10
11
12
13
14	Cash flows from financing activities:
15
16
17
18
19	Cash at the beginning of the year
20	Cash at the end of the year